Lindsey Council
Nurse Practitioner · Flower Mound, TXNPI 1295182210
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 26.7% of the total. Reporting peaked in 2023 at $353 and has fallen 63.5% since, to $129 in 2025.
Across 62 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$308
- Astellas Pharma US Inc$136
- Shield Therapeutics Inc$111
- Exeltis, USA Inc.$73
- Novo Nordisk$58
- Mayne Pharma Commercial LLC$55
- plus $413 from 14 others
What the payments were for
- Food & beverage$1,155100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $308 |
| Astellas Pharma US Inc | 6 | $136 |
| Shield Therapeutics Inc | 4 | $111 |
| Exeltis, USA Inc. | 4 | $73 |
| Novo Nordisk | 3 | $58 |
| Mayne Pharma Commercial LLC | 3 | $55 |
| Evofem Biosciences, Inc. | 2 | $48 |
| Pfizer | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Hologic Sales And Service, LLC | 1 | $44 |
| Agile Therapeutics, Inc. | 2 | $38 |
| Millicent US Inc | 1 | $34 |
| Organon | 2 | $30 |
| Myovant Sciences Inc. | 1 | $23 |
| Biogen | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| BD | 1 | $19 |
| Kesin Pharma Corporation | 1 | $17 |
| Abbott | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$1,155 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 16 | $449 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Flower Mound
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.